TIE1_BOVIN
ID TIE1_BOVIN Reviewed; 1136 AA.
AC Q06805;
DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT 01-FEB-1995, sequence version 1.
DT 03-AUG-2022, entry version 152.
DE RecName: Full=Tyrosine-protein kinase receptor Tie-1;
DE EC=2.7.10.1;
DE Flags: Precursor;
GN Name=TIE1; Synonyms=TIE, TIE-1;
OS Bos taurus (Bovine).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC Bovinae; Bos.
OX NCBI_TaxID=9913;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC TISSUE=Endothelial cell;
RX PubMed=8415706; DOI=10.1073/pnas.90.20.9355;
RA Sato T.N., Qin Y., Kozak C.A., Andus K.L.;
RT "Tie-1 and tie-2 define another class of putative receptor tyrosine kinase
RT genes expressed in early embryonic vascular system.";
RL Proc. Natl. Acad. Sci. U.S.A. 90:9355-9358(1993).
CC -!- FUNCTION: Transmembrane tyrosine-protein kinase that may modulate
CC TEK/TIE2 activity and contribute to the regulation of angiogenesis.
CC {ECO:0000250}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC -!- SUBUNIT: Heterodimer with TEK/TIE2. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC membrane protein {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Specifically expressed in developing vascular
CC endothelial cells. {ECO:0000269|PubMed:8415706}.
CC -!- PTM: Phosphorylated on tyrosine residues in response to ANGPT1, most
CC likely by TEK/TIE2. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC kinase family. Tie subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X71423; CAA50554.1; -; mRNA.
DR PIR; S57845; S57845.
DR RefSeq; NP_776390.1; NM_173965.2.
DR AlphaFoldDB; Q06805; -.
DR SMR; Q06805; -.
DR STRING; 9913.ENSBTAP00000004917; -.
DR PaxDb; Q06805; -.
DR PRIDE; Q06805; -.
DR GeneID; 280941; -.
DR KEGG; bta:280941; -.
DR CTD; 7075; -.
DR eggNOG; KOG0200; Eukaryota.
DR InParanoid; Q06805; -.
DR OrthoDB; 707342at2759; -.
DR BRENDA; 2.7.10.1; 908.
DR Proteomes; UP000009136; Unplaced.
DR GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR GO; GO:0045766; P:positive regulation of angiogenesis; IBA:GO_Central.
DR GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR CDD; cd00063; FN3; 3.
DR Gene3D; 2.60.40.10; -; 5.
DR InterPro; IPR000742; EGF-like_dom.
DR InterPro; IPR003961; FN3_dom.
DR InterPro; IPR036116; FN3_sf.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR013151; Immunoglobulin.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR000719; Prot_kinase_dom.
DR InterPro; IPR017441; Protein_kinase_ATP_BS.
DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR InterPro; IPR008266; Tyr_kinase_AS.
DR InterPro; IPR020635; Tyr_kinase_cat_dom.
DR Pfam; PF00041; fn3; 3.
DR Pfam; PF00047; ig; 1.
DR Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR PRINTS; PR00109; TYRKINASE.
DR SMART; SM00181; EGF; 3.
DR SMART; SM00060; FN3; 3.
DR SMART; SM00409; IG; 2.
DR SMART; SM00219; TyrKc; 1.
DR SUPFAM; SSF48726; SSF48726; 2.
DR SUPFAM; SSF49265; SSF49265; 2.
DR SUPFAM; SSF56112; SSF56112; 1.
DR PROSITE; PS00022; EGF_1; 3.
DR PROSITE; PS01186; EGF_2; 3.
DR PROSITE; PS50026; EGF_3; 2.
DR PROSITE; PS50853; FN3; 3.
DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE 2: Evidence at transcript level;
KW Angiogenesis; ATP-binding; Cell membrane; Disulfide bond; EGF-like domain;
KW Glycoprotein; Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding;
KW Phosphoprotein; Receptor; Reference proteome; Repeat; Signal; Transferase;
KW Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT SIGNAL 1..23
FT CHAIN 24..1136
FT /note="Tyrosine-protein kinase receptor Tie-1"
FT /id="PRO_0000024470"
FT TOPO_DOM 24..757
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 758..782
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 783..1136
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT DOMAIN 43..106
FT /note="Ig-like C2-type 1"
FT DOMAIN 212..254
FT /note="EGF-like 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 256..301
FT /note="EGF-like 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 303..343
FT /note="EGF-like 3"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 370..424
FT /note="Ig-like C2-type 2"
FT DOMAIN 444..543
FT /note="Fibronectin type-III 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 546..640
FT /note="Fibronectin type-III 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 644..737
FT /note="Fibronectin type-III 3"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 837..1116
FT /note="Protein kinase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT ACT_SITE 977
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT ECO:0000255|PROSITE-ProRule:PRU10028"
FT BINDING 843..851
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 868
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT MOD_RES 1005
FT /note="Phosphotyrosine; by autocatalysis"
FT /evidence="ECO:0000250"
FT CARBOHYD 84
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 159
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 501
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 594
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 707
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 226..235
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 229..242
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 244..253
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 317..325
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 319..331
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 333..342
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
SQ SEQUENCE 1136 AA; 124953 MW; EFF85804A041BB12 CRC64;
MVWLEPPLLL PIFFLASHVG AAVDLTLLAD LRLTEPQRFF LTCVSGEAGA GRGSDAWGPP
LLLEKDDRIV RTPRPWQPPH IARNGSSRVT VRGFSQPSDL VGVFSCVGGG GTRVLYVHNS
PGAHLLPDKV THTVNKGDTA VLSARVRKEK QTDVIWKSNG SYFYTLDRHE AQDGQFLLQL
PNVQPSSSGI YSATYLEASP LGSAFFRLIV RGCEAGRWGQ DCTKECPGCL HGGVCHDQDG
ECVCPPGFTG TRCEQACREG RFGQSCQEQC PGTSGCRGLT FCLPDPYGCS CGSGWRGSQC
QEACAPGRFG ADCHLQCQCQ NGGTCDRFSG CVCPSGWHGM HCEKSDRIPQ ILDMVSELEF
NLDTMPRINC AAAGNPFPVR GSMELRKPDG TVLLSTKAIV EPDRTTAEFE VPRLALGDSG
LWECRVSTSG GQDSRRFRIN VKVPPVPLTA PRLLAKQSRQ LVVSPLVSFS GDGPIASVRL
HYRPQDSTMA WSTIVVDPSE NVTLMNLRPK TGYSVRVQLS RPGEGGEGAW GPPTLMTTDC
PEPLLKPWLE GWHVEGPDRL RVSWSLPPVP GPLVGDGFLL RLWDGARGQE RRENVSSPQA
RTALLTGLTP GTYYQLDVRL YHCTLLGPAS PAARVLLPPS GPPAPRHLHA QALSDSEIQL
MWQRPEAAAG PISKYIVEVQ VAGGSGDPLW MDVDRPEETS TIVRGLNAST RYLFRVRASV
QGPGDWSNVV EQSTLGNGLQ IEGPVQEIHA AEEGLDQQLV LAVVGSVSAT CLTILAALLT
LACIRKSCLH RRRTFTYQSG SGEETILQFS SGTLTLTRRP KPQPEPLNYP VLEWEDITFE
DLIGEGNFGQ VIRAMIKKDG LKMNAAIKML KEYASENDHR DFAGELEVLC KLGHHPNIIN
LLGACENRGY LYIAIEYAPY GNLLDFLRKS RVLETDPAFA REHGTASTLS SRQLLRFASD
AANGMQYLSE KQFIHRDLAA RNVLVGENLA SKIADFGLSR GEEVYVKKTM GRLPVRWMAI
ESLNYSVYTT KSDVWSFGVL LWEIVSLGGT PYCGMTCAEL YEKLPQAYRM EQPRNCDDEV
YELMRQCWRD RPYERPPFAQ IALQLGRMLE ARKAYVNMSL FENFTYAGID ATAEEA